ImmunityBio, Inc. (IBRX)
8.22
-0.09
(-1.08%)
USD |
NASDAQ |
Oct 23, 16:00
8.22
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio Price : 8.22 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 8.21 | 8.355 | 8.05 | 8.22 | 5.944M |
| Oct 22, 2026 | 8.53 | 8.84 | 8.02 | 8.31 | 12.74M |
| Oct 21, 2026 | 8.79 | 8.99 | 8.32 | 8.64 | 11.51M |
| Oct 20, 2026 | 8.31 | 8.90 | 8.11 | 8.77 | 14.11M |
| Oct 19, 2026 | 9.19 | 9.697 | 8.305 | 8.42 | 19.57M |
| Oct 16, 2026 | 10.02 | 10.02 | 9.02 | 9.18 | 21.51M |
| Oct 15, 2026 | 10.20 | 10.50 | 9.815 | 10.00 | 20.01M |
| Oct 14, 2026 | 9.69 | 10.46 | 9.35 | 9.91 | 30.23M |
| Oct 13, 2026 | 10.00 | 10.06 | 9.56 | 9.80 | 11.60M |
| Oct 12, 2026 | 10.59 | 10.62 | 10.05 | 10.12 | 11.06M |
| Oct 09, 2026 | 9.95 | 10.80 | 9.87 | 10.51 | 18.66M |
| Oct 08, 2026 | 9.63 | 10.04 | 9.43 | 9.91 | 10.49M |
| Oct 07, 2026 | 9.50 | 9.93 | 9.33 | 9.75 | 11.78M |
| Oct 06, 2026 | 10.32 | 10.36 | 9.61 | 9.69 | 16.89M |
| Oct 05, 2026 | 10.76 | 10.81 | 10.12 | 10.38 | 16.87M |
| Oct 02, 2026 | 9.39 | 10.55 | 9.39 | 10.28 | 31.25M |
| Oct 01, 2026 | 9.28 | 9.40 | 9.07 | 9.28 | 12.31M |
| Sep 30, 2026 | 8.92 | 10.09 | 8.90 | 9.44 | 27.29M |
| Sep 29, 2026 | 8.52 | 8.88 | 8.52 | 8.83 | 8.367M |
| Sep 28, 2026 | 8.39 | 8.979 | 8.26 | 8.52 | 10.41M |
| Sep 25, 2026 | 8.76 | 8.84 | 8.41 | 8.44 | 5.819M |
| Sep 24, 2026 | 8.50 | 8.675 | 8.31 | 8.64 | 8.980M |
| Sep 23, 2026 | 9.26 | 9.29 | 8.60 | 8.63 | 13.95M |
| Sep 22, 2026 | 8.45 | 9.48 | 8.37 | 9.29 | 21.13M |
| Sep 21, 2026 | 8.72 | 8.87 | 8.26 | 8.45 | 12.24M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 200.10 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
Price Related Metrics
| PS Ratio | 49.74 |
| PEG Ratio | -0.0878 |
| Earnings Yield | -11.79% |
| Market Cap | 8.657B |
| PEGY Ratio | -0.0878 |